Feng, Shu https://orcid.org/0000-0002-5372-4497
Xie, Na https://orcid.org/0000-0003-3775-6277
Liu, Yongzhen
Qin, Chao https://orcid.org/0000-0003-0393-1751
Savas, Ali Can https://orcid.org/0000-0002-2630-9765
Wang, Ting-Yu
Li, Shutong
Rao, Youliang
Shambayate, Alexandra
Chou, Tsui-Fen https://orcid.org/0000-0003-2410-2186
Brenner, Charles https://orcid.org/0000-0002-4955-3226
Huang, Canhua https://orcid.org/0000-0003-2247-7750
Feng, Pinghui https://orcid.org/0000-0002-8494-0205
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute on Aging (AG070904)
U.S. Department of Health & Human Services | NIH | National Cancer Institute (CA285192)
Division of Intramural Research, National Institute of Allergy and Infectious Diseases (AI180537)
National Natural Science Foundation of China (81821002)
Article History
Received: 22 November 2023
Accepted: 4 October 2024
First Online: 21 November 2024
Competing interests
: C.B. is a chief scientific advisor of ChromaDex and co-founder of Alphina Therapeutics. P.F. is a consultant for Marc J Bern & Partners. All other authors declare no competing interests.